William William

Dr. William William


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Lung Cancer
Verified
Journal Article
Closed access
GSGustavo Schvartsman
Gustavo Schvartsman
SPS. Andrew Peng
S. Andrew Peng
GBGiorgios Bis
Giorgios Bis
JLJ. Jack Lee
J. Jack Lee
MBMarcelo F.K. Benveniste
Marcelo F.K. Benveniste
WWWilliam William
William William

1 April 2015 in Journal of Thoracic Oncology
Verified
Journal Article
Open access
PDF file
JZJianjun Zhang
Jianjun Zhang
KGKathryn A. Gold
Kathryn A. Gold
HLHeather Y. Lin
Heather Y. Lin
SSStephen G. Swisher
Stephen G. Swisher
YXYan Xing
Yan Xing
WWWilliam William
William William
Introduction Tumor size is a known prognostic factor for early stage non–small-cell lung cancer (NSCLC), but its significance in node-positive and locally invasive NSCLC has not been extensively characterized. We queried the Surveillance, Epidemiology, and End Results database to evaluate the prognostic value of tumor size for early stage and node-positive and locally invasive NSCLC. Methods Patients in Surveillance, Epidemiology, and End Results registry with NSCLC diagnosed between 1998 and 2003 were analyzed. Tumor size was analyzed as a continuous variable. Other demographic variables included age, gender, race, histology, primary tumor extension, node status, and primary treatment modality (surgery vs. radiation). The Kaplan–Meier method was used to estimate overall survival (OS). Cox proportional hazard model was used to evaluate whether tumor size was an independent prognostic factor. Results In all, 52,287 eligible patients were subgrouped based on tumor extension and node status. Tumor size had a significant effect on OS in all subgroups defined by tumor extension or node status. In addition, tumor size also had statistically significant effect on OS in 15 of 16 subgroups defined by tumor extension and nodal status after adjustment for other clinical variables. Our model incorporating tumor size had significantly better predictive accuracy than our alternative model without tumor size. Conclusions Tumor size is an independent prognostic factor, for early stage and node-positive and locally invasive disease. Prediction tools, such as nomograms, incorporating more detailed information not captured in detail by the routine tumor, node, metastasis classification, may improve prediction accuracy of OS in NSCLC.

1 February 2016 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
WWWilliam William
William William
VPVassiliki Papadimitrakopoulou
Vassiliki Papadimitrakopoulou
JLJ. Jack Lee
J. Jack Lee
LMLi Mao
Li Mao
ECEzra E. W. Cohen
Ezra E. W. Cohen
SLScott M. Lippman
Scott M. Lippman
Oral premalignant lesions (OPLs), often clinically recognized as leukoplakia or erythroplakia, are considered risk factors for development of oral cancer. Oral premalignant lesions are a clinical manifestation of what can be a diffuse process of field cancerization. In patients with treated head and neck cancers, field cancerization contributes to development of second primary tumors, a significant cause of morbidity and mortality.1 Systemic chemoprevention has been proposed as a method to address the entire mucosal field at risk to halt or reverse carcinogenesis.2 However, a standard head neck cancer chemoprevention approach has yet to be developed, despite extensive previous clinical investigations of various retinoids,3-7 interferon,8 celecoxib,9 ONYX-015,10 and Bowman Birk inhibitor concentrate,11 among other candidate preventive drugs.

1 December 2017 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
WWWilliam William
William William
LFLei Feng
Lei Feng
RFRenata Ferrarotto
Renata Ferrarotto
LGLawrence Ginsberg
Lawrence Ginsberg
MKMerrill Kies
Merrill Kies
EKEdward S. Kim
Edward S. Kim

1 November 2015 in European Journal of Cancer
Verified
Journal Article
Closed access
GMGustavo Marta
Gustavo Marta
RRRachel Riera
Rachel Riera
PBPaolo Bossi
Paolo Bossi
LZLai-ping Zhong
Lai-ping Zhong
LLLisa Licitra
Lisa Licitra
Luiz P. KowalskiLuiz P. Kowalski
Luiz P. Kowalski

10 November 2015 in Cancer
Verified
Journal Article
Open access
PDF file
YXYan Xing
Yan Xing
JZJianjun Zhang
Jianjun Zhang
HLHeather Lin
Heather Lin
KGKathryn A. Gold
Kathryn A. Gold
ESErich M. Sturgis
Erich M. Sturgis
WWWilliam William
William William
BACKGROUND: The current head and neck squamous cell carcinoma (HNSCC) staging system may not capture the full prognostic implications of regional lymph node involvement. This study investigated the impact of the level of lymph node metastasis (LNM) on survival.METHODS: The Surveillance, Epidemiology, and End Results registry was queried for oral cavity (OC), oropharynx (OP), larynx (LAR), and hypopharynx (HP) HNSCC. A multivariate Cox proportional hazards model was used to evaluate whether the level of LNM was an independent prognostic factor. Site‐specific recursive‐partitioning analysis was performed to classify patients into different risk groups.RESULTS: In all, 14,499 patients, including OC (n = 2463), OP (n = 8567), LAR (n = 2332), and HP patients (n = 1137), were analyzed. Both the American Joint Committee on Cancer (AJCC) N classification and the level of LNM showed significant effects on overall survival (OS) in patients with OC, OP, or LAR HNSCC but not in patients with HP HNSCC. In patients with N2 disease, the AJCC subclassification (N2a, N2b, or N2c) was significantly associated with the OS of patients with OP and LAR HNSCC but not with the OS of patients with OC or HP HNSCC, whereas the level of LNM (primary, secondary, or tertiary) was significantly associated with the OS of patients with OC, OP, and LAR HNSCC but not HP HNSCC. With recursive‐partitioning analysis, a simple, primary site–specific prognostic tool integrating the AJCC T and N classifications and the level of LNM was designed, and it could be easily used by health care providers in clinic.CONCLUSIONS: The level of LNM is an independent prognostic factor for patients with locally advanced HNSCC and could add to the prognostic value of AJCC T and N classifications in patients with locally advanced HNSCC.Cancer2016;122:534–545.©2015 American Cancer Society.